Riskpilot← Back to searchSign inGet full accessSymbiosa AB
ABActiveOrg 5568028145Sporrvägen 20Non-specialised retail sale of predominately food, beverages or tobacco · NACE 4711Est. 20102 employees
Revenue 2025
SEK 46K
+53% vs 2024
EBITDA margin
15.2%
+800% vs 2024
Equity ratio
111.8%
Financial strength
Net profit 2025
SEK 5K
+600% vs 2024
| Revenue | SEK 46K | +53% |
| EBITDA | SEK 7K | +800% |
| Net profit | SEK 5K | +600% |
| Total assets | SEK 102K | -23% |
| Equity | SEK 114K | +6% |
| Employees | 2 | — |
Legal name
Symbiosa AB
Org number
5568028145
Legal form
Aktiebolag
NACE code
4711 · Non-specialised retail sale of predominately food, beverages or tobacco
Founded
25 mars 2010
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konsult- och reklamverksamhet, personal- uthyrning och tillhandahållande av personalfunktioner, varuförsäljning till dagligvaruhandeln, tillverkning av dagligvaruprodukter, transport av gods, matservering, eventarrangemang, kurs- och föreläsningsverksamhet inom hälsa och träning, tillhandahålla tjänster avseende redovisning och administration, äga och för valta fast och lös egendom, bedriva handel med värdepapper, samt annan därmed förenlig verksamhet.
Address
Sporrvägen 20
Email
hubbe83@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 57 | 140 | 6 | 30 | 46 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −48 | 1 | — | −1 | 7 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −48 | 1 | 0 | −1 | 7 |
| Net financials | 68 | — | — | — | — |
| Profit before tax | 20 | 1 | 0 | −1 | 6 |
| Tax | −1 | −0 | −0 | −0 | −1 |
| Net profit | 19 | 1 | 0 | −1 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 102 | 101 | 105 | 132 | 102 |
| Equity | 109 | 109 | 109 | 108 | 114 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 | 9 | 4 | 23 | 12 |
| Total debt | 6 | 9 | 4 | 23 | 12 |
EBITDA margin
15.2%
This company
15.8%
Market median
+4% vs market
20212025
Equity ratio
111.8%
This company
38.2%
Market median
+193% vs market
20212025
Return on equity
4.4%
This company
18.4%
Market median
-76% vs market
20212025
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20212025
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20212025
Debt / equity
-0.11×
This company
0.62×
Market median
+118% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Symbiosa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Richard Leo Houbaer | Board of Directors | 0 companies |
| Eva Karin Elisabeth Houbaer | Deputy Board Member | 0 companies |